EUVIMEDEUVIMED entdecken
Leitlinie

ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer: 2025 Update

Expert Panel on GYN and OB Imaging, Erica B Stein, Aradhana M Venkatesan, Esma A Akin, Emily Barrows, Parul Barry, Nicole M Hindman, Chenchan Huang, Gaiane M Rauch, Madeleine Sertic, Krista Suarez-Weiss, Jason D Wright und 1 weitere

Journal of the American College of Radiology · 2025-11 · 22 (11) · S689-S698

DOI: 10.1016/j.jacr.2025.08.033 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the American College of Radiology, 2025-11. Verfasst von Expert Panel on GYN and OB Imaging und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan Medical Center, Ann Arbor, Michigan. Electronic address: erst@med.umich.edu. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Diagnostic Imaging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Breast Cancer Research Foundation, Pittsburgh Foundation, Aid for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer remains the sixth most common cause of cancer mortality in women in the United States and is a leading cause of mortality among patients with gynecologic malignancies. Imaging plays an important role in pretreatment staging of epithelial ovarian cancers, the evaluation of posttreatment response, and follow-up. Accurate pretreatment imaging is integral to determine appropriate first-line therapy. By delineating the extent of disease, imaging can assist decision making regarding the likelihood of optimal primary cytoreduction or need for neoadjuvant chemotherapy when optimal cytoreduction is not felt to be achievable. Contrast-enhanced CT serves as a mainstay modality for the pretreatment assessment of ovarian cancer, with MRI, PET/CT, and, in some instances, PET/MRI used in the pretreatment setting. CT and PET/CT are also integral to assessing response, including in the suspected recurrence setting, with MRI and PET/MRI being used in select cases. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsDiagnostic ImagingHumansFemaleNeoplasm StagingUnited StatesSocieties, MedicalEvidence-Based MedicineMagnetic Resonance ImagingContrast Media

Stichwörter der Autor:innen

AUCAppropriate Use CriteriaAppropriateness Criteriaimaging evaluationovarian cancerrecurrencestaging

Substanzen

Contrast Media

Autor:innen und Institutionen

  • University of Michigan Medical Center, Ann Arbor, Michigan. Electronic address: erst@med.umich.edu.
  • Panel Chair, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • George Washington University Hospital, Washington, District of Columbia; ACR Commission on Nuclear Medicine and Molecular Imaging.
  • Virginia Commonwealth University Health/Virginia Commonwealth University School of Medicine, Richmond, Virginia; American College of Obstetricians and Gynecologists.
  • University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania; Commission on Radiation Oncology.
  • New York University School of Medicine, New York, New York.

Förderung

  • Breast Cancer Research Foundation
  • Pittsburgh Foundation
  • Aid for Cancer Research
  • University of Michigan

Zitieren

APA

Expert Panel on GYN and OB Imaging, Stein, E. B., Venkatesan, A. M., Akin, E. A., Barrows, E., Barry, P., Hindman, N. M., Huang, C., Rauch, G. M., Sertic, M., Suarez-Weiss, K., Wright, J. D., & Wasnik, A. P. (2025). ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer: 2025 Update. Journal of the American College of Radiology, 22(11), S689-S698. https://doi.org/10.1016/j.jacr.2025.08.033

Vancouver

Expert Panel on GYN and OB Imaging, Stein EB, Venkatesan AM, Akin EA, Barrows E, Barry P, et al. ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer: 2025 Update. Journal of the American College of Radiology. 2025;22(11):S689-S698. doi:10.1016/j.jacr.2025.08.033

BibTeX
@article{ExpertPanelonGYNandOBImaging2025,
  author = {Expert Panel on GYN and OB Imaging, Expert Panel on GYN and OB Imaging and Stein, Erica B and Venkatesan, Aradhana M and Akin, Esma A and Barrows, Emily and Barry, Parul and Hindman, Nicole M and Huang, Chenchan and Rauch, Gaiane M and Sertic, Madeleine and Suarez-Weiss, Krista and Wright, Jason D and Wasnik, Ashish P},
  title = {ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer: 2025 Update},
  journal = {Journal of the American College of Radiology},
  year = {2025},
  volume = {22},
  number = {11},
  pages = {S689--S698},
  doi = {10.1016/j.jacr.2025.08.033}
}
Kostenlos starten →